Joel Greenblatt fit · Magic Formula - ROIC alto + EV/EBIT barato
Is BioCryst Pharmaceuticals, Inc. (BCRX) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
61/100
CSeñales mixtas
5/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a BCRX
EBIT/EV yield ≥ 10%
clave14.8%
ROIC ≥ 25%
clave93.9%
EV/EBIT ≤ 12
6.8x
Gross margin ≥ 30%
97.7%
Cómo se valora BCRX en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.74B
PER (TTM)
-
ROIC (TTM)
-121.96%
Margen bruto
18.89%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is BCRX's Joel Greenblatt fit score?
BCRX scores 61/100 on our Joel Greenblatt fit engine - grade C. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own BCRX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends BCRX.
How often is this score updated?
BCRX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende BCRX personalmente.